eadn9857 2024 30 august (ATCC)
98
Structured Review
ATCC
eadn9857 2024 30 august
Eadn9857 2024 30 August, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 642 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/eadn9857+2024+30+august/GR-20/pm39213364-294-1-16
Average 98 stars, based on 642 article reviews
Eadn9857 2024 30 August, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 642 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/eadn9857+2024+30+august/GR-20/pm39213364-294-1-16
Average 98 stars, based on 642 article reviews
eadn9857 2024 30 august - by Bioz Stars,
2026-10
98/100 stars
Images
Related Articles
other:Article Title: Multi-armored allogeneic MUC1 CAR T cells enhance efficacy and safety in triple-negative breast cancer. Article Snippet: 10, eadn9857 (2024) 30 August 2024 16 of 21 PCS- 300- 010), and |